Market News & Insights.

Earnings call transcript: Industries Qatar posts weak H1 2026 results as revenue misses

Mortgage applications slip 0.4% in latest week, MBA reports

How Howard Hughes Holdings’ (HHH) Vantage Acquisition Sets the Stage for Compound Growth?

Anthropic surpasses OpenAI in Q2 revenue for the first time

Turkey offers Syria help in oil and gas exploration

Opaleye Management buys $24,206 of Grace Therapeutics stock

Argus upgrades APA stock rating to buy on strong earnings beat

Stifel cuts Vivmark Residential stock price target on model update

Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.

The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.

Guggenheim raises Amylyx stock price target on trial results

Nebius says its $5 billion convertible underscores data centre demand

Ocean Capital Acquisition Corp announces board changes and new independent directors

SK Hynix launches $28.6 billion share buyback and cancellation

LGES starts production at Lansing battery plant in US

UBS urges investors to look past the US as AI concentration risk grows

Could Ford Stock Reach $30 by 2030?

Columbus Q2 2026 slides: return to growth after five-quarter decline

Uber (UBER) Bets On Drones As Its Delivery Engine Accelerates

Hays announces committee changes, disbands sustainability panel

Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play

"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

Stifel raises Okta stock price target to $160 on identity security

Why is SK hynix stock rallying today?

Why is WhiteFiber stock plunging today?

Earnings call transcript: Borosil Q1 2026 profit falls as margins narrow

Canada closes higher helped by rally in mining stocks as tariffs deal linger

Soquimich B ADR earnings beat by $0.40, revenue topped estimates

5 Things to Know Before the Stock Market Opens on Wednesday

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

Buying Bullsh*t In "4 Easy Payments"

Buying Bullsh*t In "4 Easy Payments"  Submitted by QTR's Fringe Finance I have been gently touching on what a horrible idea one sector has been since the inception of this blog. And just this week, it looks like cracks are starting to form in the space via one of its largest and…